328 related articles for article (PubMed ID: 17443135)
1. Novel nerve-agent antidote design based on crystallographic and mass spectrometric analyses of tabun-conjugated acetylcholinesterase in complex with antidotes.
Ekström FJ; Astot C; Pang YP
Clin Pharmacol Ther; 2007 Sep; 82(3):282-93. PubMed ID: 17443135
[TBL] [Abstract][Full Text] [Related]
2. Crystal structures of acetylcholinesterase in complex with HI-6, Ortho-7 and obidoxime: structural basis for differences in the ability to reactivate tabun conjugates.
Ekström F; Pang YP; Boman M; Artursson E; Akfur C; Börjegren S
Biochem Pharmacol; 2006 Aug; 72(5):597-607. PubMed ID: 16876764
[TBL] [Abstract][Full Text] [Related]
3. In silico pharmacophore model for tabun-inhibited acetylcholinesterase reactivators: a study of their stereoelectronic properties.
Bhattacharjee AK; Kuca K; Musilek K; Gordon RK
Chem Res Toxicol; 2010 Jan; 23(1):26-36. PubMed ID: 20028185
[TBL] [Abstract][Full Text] [Related]
4. Catalytic-site conformational equilibrium in nerve-agent adducts of acetylcholinesterase: possible implications for the HI-6 antidote substrate specificity.
Artursson E; Andersson PO; Akfur C; Linusson A; Börjegren S; Ekström F
Biochem Pharmacol; 2013 May; 85(9):1389-97. PubMed ID: 23376121
[TBL] [Abstract][Full Text] [Related]
5. An evaluation of therapeutic and reactivating effects of newly developed oximes (K156, K203) and commonly used oximes (obidoxime, trimedoxime, HI-6) in tabun-poisoned rats and mice.
Kassa J; Karasova J; Musilek K; Kuca K
Toxicology; 2008 Jan; 243(3):311-6. PubMed ID: 18054821
[TBL] [Abstract][Full Text] [Related]
6. Oximes: Reactivators of phosphorylated acetylcholinesterase and antidotes in therapy against tabun poisoning.
Kovarik Z; Calić M; Sinko G; Bosak A; Berend S; Vrdoljak AL; Radić B
Chem Biol Interact; 2008 Sep; 175(1-3):173-9. PubMed ID: 18501341
[TBL] [Abstract][Full Text] [Related]
7. In vitro and in vivo evaluation of pyridinium oximes: mode of interaction with acetylcholinesterase, effect on tabun- and soman-poisoned mice and their cytotoxicity.
Calić M; Vrdoljak AL; Radić B; Jelić D; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Feb; 219(1-3):85-96. PubMed ID: 16332406
[TBL] [Abstract][Full Text] [Related]
8. Pretreatment with pyridinium oximes improves antidotal therapy against tabun poisoning.
Lucić Vrdoljak A; Calić M; Radić B; Berend S; Jun D; Kuca K; Kovarik Z
Toxicology; 2006 Nov; 228(1):41-50. PubMed ID: 16982122
[TBL] [Abstract][Full Text] [Related]
9. Reactivation of tabun-hAChE investigated by structurally analogous oximes and mutagenesis.
Artursson E; Akfur C; Hörnberg A; Worek F; Ekström F
Toxicology; 2009 Nov; 265(3):108-14. PubMed ID: 19761810
[TBL] [Abstract][Full Text] [Related]
10. Kinetic analysis of reactivation and aging of human acetylcholinesterase inhibited by different phosphoramidates.
Worek F; Aurbek N; Koller M; Becker C; Eyer P; Thiermann H
Biochem Pharmacol; 2007 Jun; 73(11):1807-17. PubMed ID: 17382909
[TBL] [Abstract][Full Text] [Related]
11. Reactivators of acetylcholinesterase inhibited by organophosphorus nerve agents.
Mercey G; Verdelet T; Renou J; Kliachyna M; Baati R; Nachon F; Jean L; Renard PY
Acc Chem Res; 2012 May; 45(5):756-66. PubMed ID: 22360473
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of monoquaternary pyridinium oximes potency to reactivate tabun-inhibited human acetylcholinesterase.
Odzak R; Calić M; Hrenar T; Primozic I; Kovarik Z
Toxicology; 2007 Apr; 233(1-3):85-96. PubMed ID: 16962227
[TBL] [Abstract][Full Text] [Related]
13. [A comparison of the efficacy of the reactivators of acetylcholinesterase inhibited with tabun].
Cabal J; Kuca K; Jun D; Bajgar J; Hrabinová M
Ceska Slov Farm; 2005 Jul; 54(4):192-5. PubMed ID: 16124202
[TBL] [Abstract][Full Text] [Related]
14. Aging of cholinesterases phosphylated by tabun proceeds through O-dealkylation.
Carletti E; Li H; Li B; Ekström F; Nicolet Y; Loiodice M; Gillon E; Froment MT; Lockridge O; Schopfer LM; Masson P; Nachon F
J Am Chem Soc; 2008 Nov; 130(47):16011-20. PubMed ID: 18975951
[TBL] [Abstract][Full Text] [Related]
15. An in vitro comparative study on the reactivation of nerve agent-inhibited guinea pig and human acetylcholinesterases by oximes.
Luo C; Tong M; Chilukuri N; Brecht K; Maxwell DM; Saxena A
Biochemistry; 2007 Oct; 46(42):11771-9. PubMed ID: 17900152
[TBL] [Abstract][Full Text] [Related]
16. Chromatographic preparation and kinetic analysis of interactions between tabun enantiomers and acetylcholinesterase.
Tenberken O; Thiermann H; Worek F; Reiter G
Toxicol Lett; 2010 Jun; 195(2-3):142-6. PubMed ID: 20347021
[TBL] [Abstract][Full Text] [Related]
17. Structural changes of phenylalanine 338 and histidine 447 revealed by the crystal structures of tabun-inhibited murine acetylcholinesterase.
Ekström F; Akfur C; Tunemalm AK; Lundberg S
Biochemistry; 2006 Jan; 45(1):74-81. PubMed ID: 16388582
[TBL] [Abstract][Full Text] [Related]
18. Novel series of bispyridinium compounds bearing a (Z)-but-2-ene linker--synthesis and evaluation of their reactivation activity against tabun and paraoxon-inhibited acetylcholinesterase.
Musilek K; Holas O; Kuca K; Jun D; Dohnal V; Opletalova V; Dolezal M
Bioorg Med Chem Lett; 2007 Jun; 17(11):3172-6. PubMed ID: 17383875
[TBL] [Abstract][Full Text] [Related]
19. Phosphoryl oxime inhibition of acetylcholinesterase during oxime reactivation is prevented by edrophonium.
Luo C; Saxena A; Smith M; Garcia G; Radić Z; Taylor P; Doctor BP
Biochemistry; 1999 Aug; 38(31):9937-47. PubMed ID: 10433700
[TBL] [Abstract][Full Text] [Related]
20. Can hydroxylamine be a more potent nucleophile for the reactivation of tabun-inhibited AChE than prototype oxime drugs? An answer derived from quantum chemical and steered molecular dynamics studies.
Lo R; Ganguly B
Mol Biosyst; 2014 Jul; 10(9):2368-83. PubMed ID: 24964273
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
